Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation
NCT: NCT07722832 · NOT_YET_RECRUITING
Brief Summary
As part of post-marketing clinical monitoring and with a view to applying for the digital medical device Quitoxil® to be included on the LPPR list, this prospective, multicentre, controlled, randomised clinical trial aims to evaluate the clinical impact of support provided by Quitoxil® as an adjunct to conventional management for patients undergoing smoking cessation who have a tobacco use disorder.
Frequently Asked Questions
What is Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation?
Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation is a clinical trial registered under NCT07722832. Current status: NOT_YET_RECRUITING.
What is the status of NCT07722832?
The current status of NCT07722832 (Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation) is: NOT_YET_RECRUITING.
When did Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation start?
Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation started on 2026-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.